Research ArticleArticle
Apixaban and Rosuvastatin Pharmacokinetics in Nonalcoholic Fatty Liver Disease
Rommel G. Tirona, Zahra Kassam, Ruth Strapp, Mala Ramu, Catherine Zhu, Melissa Liu, Ute I. Schwarz, Richard B. Kim, Bandar Al-Judaibi and Melanie D Beaton
Drug Metabolism and Disposition February 22, 2018, dmd.117.079624; DOI: https://doi.org/10.1124/dmd.117.079624
Rommel G. Tirona
1 The University of Western Ontario;
Zahra Kassam
1 The University of Western Ontario;
Ruth Strapp
2 Lawson Health Research Institute;
Mala Ramu
2 Lawson Health Research Institute;
Catherine Zhu
1 The University of Western Ontario;
Melissa Liu
1 The University of Western Ontario;
Ute I. Schwarz
1 The University of Western Ontario;
Richard B. Kim
1 The University of Western Ontario;
Bandar Al-Judaibi
3 University of Rochester Medical Center;
Melanie D Beaton
4 Western University
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Apixaban and Rosuvastatin Pharmacokinetics in Nonalcoholic Fatty Liver Disease
Rommel G. Tirona, Zahra Kassam, Ruth Strapp, Mala Ramu, Catherine Zhu, Melissa Liu, Ute I. Schwarz, Richard B. Kim, Bandar Al-Judaibi and Melanie D Beaton
Drug Metabolism and Disposition February 22, 2018, dmd.117.079624; DOI: https://doi.org/10.1124/dmd.117.079624
Research ArticleArticle
Apixaban and Rosuvastatin Pharmacokinetics in Nonalcoholic Fatty Liver Disease
Rommel G. Tirona, Zahra Kassam, Ruth Strapp, Mala Ramu, Catherine Zhu, Melissa Liu, Ute I. Schwarz, Richard B. Kim, Bandar Al-Judaibi and Melanie D Beaton
Drug Metabolism and Disposition February 22, 2018, dmd.117.079624; DOI: https://doi.org/10.1124/dmd.117.079624
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement